You Position: Home > Paper

Clinical observation on Songlingxuemaikang combined with losartan in treatment of female menopausal bypertension

( views:333, downloads:64 )
Author:
No author available
Journal Title:
Chinese Journal of Primary Medicine and Pharmacy
Issue:
24
DOI:
10.3760/cma.j.issn.1008-6706.2011.24.007
Key Word:
更年期综合症;高血压;女(雌)性;松龄血脉康;氯沙坦;Menopausal syndrome;Hypertension;Female;Songlingxuemaikang;Losartan

Abstract: Objective To explore the effect of Songlingxuemaikang combined with losartan on the blood pressure and quality of life in female patients with menopausal hypertension.Methods 87 female patients with menopausal hypertension were randomly divided into combined group (Songlingxuemaikang combined with losartan group,44 cases) and the control group(losartan alone,43 cases).Before and after treatment the ambulatory blood pressure (ABMP) was monitored for 24h,and blood lipids and clinical symptoms were observed.Results After two months treatment,the blood pressure variability and nighttime blood pressure decrease rate of the combination group significantly reduced,and better than those of the control group( all P <0.05) ;The effective rate and efficiency rate of the combination group were 90.9%,63.6% respectively,and was higher than 74.4%,39.5% in the control group( x2 =4.15,5.06,all P < 0.05 ).The clinical symptoms improving,total cholesterol ( TC ) reducing,density lipoprotein (LDL-C) lowing in the combination group was superior to the control group( all P < 0.05).Conclusion Songlingxuemaikang combined with losartan in treatment of female patients with menopausal hypertension had a good antihypertensive effect,and could reduce blood pressure variability in menopausal women,improve the symptoms of menopause and lipid metabolism,incresse the quality of lfie of patients with menopausal hypertensive.

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn